110 related articles for article (PubMed ID: 26793999)
1. The protein kinase IKKepsilon contributes to tumour growth and tumour pain in a melanoma model.
Möser CV; Meissner M; Laarmann K; Olbrich K; King-Himmelreich TS; Wolters MC; Geisslinger G; Niederberger E
Biochem Pharmacol; 2016 Mar; 103():64-73. PubMed ID: 26793999
[TBL] [Abstract][Full Text] [Related]
2. The Specific IKKε/TBK1 Inhibitor Amlexanox Suppresses Human Melanoma by the Inhibition of Autophagy, NF-κB and MAP Kinase Pathways.
Möller M; Wasel J; Schmetzer J; Weiß U; Meissner M; Schiffmann S; Weigert A; Möser CV; Niederberger E
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630674
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the protein kinase IKKepsilon attenuates neuropathic pain in mice.
Möser CV; Möller M; Fleck SC; Thomas D; Geisslinger G; Niederberger E
Neuropharmacology; 2019 Mar; 146():198-211. PubMed ID: 30528326
[TBL] [Abstract][Full Text] [Related]
4. The protein kinase IKKε is a potential target for the treatment of inflammatory hyperalgesia.
Möser CV; Kynast K; Baatz K; Russe OQ; Ferreirós N; Costiuk H; Lu R; Schmidtko A; Tegeder I; Geisslinger G; Niederberger E
J Immunol; 2011 Sep; 187(5):2617-25. PubMed ID: 21813779
[TBL] [Abstract][Full Text] [Related]
5. IKKε aggravates inflammatory response via activation of NF-κB in rheumatoid arthritis.
Zhou LF; Zeng W; Sun LC; Wang Y; Jiang F; Li X; Zheng Y; Wu GM
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):2126-2133. PubMed ID: 29687872
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer.
Bishop RT; Marino S; de Ridder D; Allen RJ; Lefley DV; Sims AH; Wang N; Ottewell PD; Idris AI
Cancer Lett; 2019 May; 450():76-87. PubMed ID: 30790681
[TBL] [Abstract][Full Text] [Related]
7. Silencing of IKKε using siRNA inhibits proliferation and invasion of glioma cells in vitro and in vivo.
Li H; Chen L; Zhang A; Wang G; Han L; Yu K; Pu P; Kang C; Huang Q
Int J Oncol; 2012 Jul; 41(1):169-78. PubMed ID: 22552702
[TBL] [Abstract][Full Text] [Related]
8. Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro.
Zhou Z; Qi J; Lim CW; Kim JW; Kim B
Toxicology; 2020 Nov; 444():152579. PubMed ID: 32905826
[TBL] [Abstract][Full Text] [Related]
9. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells.
Marín YE; Wall BA; Wang S; Namkoong J; Martino JJ; Suh J; Lee HJ; Rabson AB; Yang CS; Chen S; Ryu JH
Melanoma Res; 2007 Oct; 17(5):274-83. PubMed ID: 17885582
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways.
Amschler K; Schön MP; Pletz N; Wallbrecht K; Erpenbeck L; Schön M
J Invest Dermatol; 2010 Apr; 130(4):1073-86. PubMed ID: 19940859
[TBL] [Abstract][Full Text] [Related]
11. IκB-Kinase-epsilon (IKKε) over-expression promotes the growth of prostate cancer through the C/EBP-β dependent activation of IL-6 gene expression.
Péant B; Gilbert S; Le Page C; Poisson A; L'Ecuyer E; Boudhraa Z; Bienz MN; Delvoye N; Saad F; Mes-Masson AM
Oncotarget; 2017 Feb; 8(9):14487-14501. PubMed ID: 27577074
[TBL] [Abstract][Full Text] [Related]
12. KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment.
Schön M; Wienrich BG; Kneitz S; Sennefelder H; Amschler K; Vöhringer V; Weber O; Stiewe T; Ziegelbauer K; Schön MP
J Natl Cancer Inst; 2008 Jun; 100(12):862-75. PubMed ID: 18544741
[TBL] [Abstract][Full Text] [Related]
13. Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth.
Yang J; Pan WH; Clawson GA; Richmond A
Cancer Res; 2007 Apr; 67(7):3127-34. PubMed ID: 17409419
[TBL] [Abstract][Full Text] [Related]
14. Andrographolide inhibits melanoma tumor growth by inactivating the TLR4/NF-κB signaling pathway.
Zhang QQ; Zhou DL; Ding Y; Liu HY; Lei Y; Fang HY; Gu QL; He XD; Qi CL; Yang Y; Lan T; Li JC; Gong P; Wu XY; Yang X; Li WD; Wang LJ
Melanoma Res; 2014 Dec; 24(6):545-55. PubMed ID: 25244079
[TBL] [Abstract][Full Text] [Related]
15. IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts.
House CD; Grajales V; Ozaki M; Jordan E; Wubneh H; Kimble DC; James JM; Kim MK; Annunziata CM
BMC Cancer; 2018 May; 18(1):595. PubMed ID: 29801480
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of DUSP6 phosphatase stimulate tumourigenesis in a molecularly distinct melanoma subtype.
Li W; Song L; Ritchie AM; Melton DW
Pigment Cell Melanoma Res; 2012 Mar; 25(2):188-99. PubMed ID: 22171919
[TBL] [Abstract][Full Text] [Related]
17. NEMO-binding domain peptide inhibits proliferation of human melanoma cells.
Ianaro A; Tersigni M; Belardo G; Di Martino S; Napolitano M; Palmieri G; Sini M; De Maio A; Ombra M; Gentilcore G; Capone M; Ascierto M; Satriano RA; Farina B; Faraone-Mennella M; Ascierto PA; Ialenti A
Cancer Lett; 2009 Feb; 274(2):331-6. PubMed ID: 19004544
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C in melanoma.
Oka M; Kikkawa U
Cancer Metastasis Rev; 2005 Jun; 24(2):287-300. PubMed ID: 15986138
[TBL] [Abstract][Full Text] [Related]
19. IKKε regulates the breast cancer stem cell phenotype.
Orlova Z; Pruefer F; Castro-Oropeza R; Ordaz-Ramos A; Zampedri C; Maldonado V; Vazquez-Santillan K; Melendez-Zajgla J
Biochim Biophys Acta Mol Cell Res; 2019 Apr; 1866(4):598-611. PubMed ID: 30615901
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
